EndoChoice Holdings Priced, NYSE: GI

Sells gastrointestinal endoscopy systems with wide field-of-view cameras.

Industry: Health Care

Latest Trade: $8.00 0.00 (0.0%)

First Day Return: +13.3%

Return from IPO: -46.7%

Industry: Health Care

We are a medical device company focused exclusively on designing and commercializing a platform of innovative products for GI caregivers. We currently serve over 2,500 GI departments that perform endoscopic procedures, which represent approximately one-third of the U.S. market. We offer a comprehensive range of products and services that span single-use devices and infection control products, pathology and imaging systems. In December 2013, we began limited commercialization of our Fuse full spectrum endoscopy system. Our Fuse system enables GI specialists to see more than twice the anatomy at any one time compared to standard, forward-viewing colonoscopes and has been clinically demonstrated to detect 69% more pre-cancerous polyps than standard colonoscopes. We believe our commitment to continuing innovation and focus on GI specialists provides us with the unique capability to meet their evolving needs. We intend to leverage our broad product platform, established customer relationships, commercial infrastructure and Fuse technology to set a new standard of care for the global GI market.
more less
IPO News for EndoChoice Holdings
more
IPO Data
IPO File Date 05/05/2015
Offer Price $15.00
Price Range $15.00 - $17.00
Offer Shares (mm) 6.4
Deal Size ($mm) $95
IPO Data
IPO Date 06/04/2015
Offer Price $15.00
Price Range $15.00 - $17.00
Offer Shares (mm) 6.4
Deal Size ($mm) $95
Underwriters
more
Company Data
Headquarters Alpharetta, GA
Founded 2008
Employees 418
Website www.endochoice.com